Despite an early, aggressive approach to mobilization in a study population that included patients with acute lung injury, morbidly obese patients, patients with shock requiring vasoactive infusions, and patients receiving ongoing renal-replacement therapy, there were very few adverse events, none of which were consequential with respect to outcome